Actarit

● Article ● Talk ● Language ● Watch ● Edit

Actarit is a disease-modifying antirheumatic drug (DMARD) developed in Japan for use in rheumatoid arthritis.^[1]

Actarit
Clinical data

AHFS/Drugs.com	International Drug Names
ATC code	None
Identifiers
IUPAC name (4-Acetamidophenyl)acetic acid
CAS Number	18699-02-0^N
PubChem CID	2018
ChemSpider	1941^Y
UNII	HW5B6351RZ
KEGG	D01395^Y
ChEMBL	ChEMBL1226203^N
CompTox Dashboard (EPA)	DTXSID0020020
ECHA InfoCard	100.038.631
Chemical and physical data
Formula	C₁₀H₁₁NO₃
Molar mass	193.202 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES O=C(O)Cc1ccc(cc1)NC(=O)C
InChI InChI=1S/C10H11NO3/c1-7(12)11-9-4-2-8(3-5-9)6-10(13)14/h2-5H,6H2,1H3,(H,11,12)(H,13,14)^Y Key:MROJXXOCABQVEF-UHFFFAOYSA-N^Y
^NY (what is this?) (verify)

References

^ Takeba Y, Suzuki N, Wakisaka S, Nagafuchi H, Mihara S, Kaneko A, et al. (January 1999). "Effects of actarit on synovial cell functions in patients with rheumatoid arthritis". The Journal of Rheumatology. 26 (1): 25–33. PMID 9918236.

This antineoplasticorimmunomodulatory drug article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Actarit&oldid=1154587043" Last edited on 13 May 2023, at 12:31

●This page was last edited on 13 May 2023, at 12:31 (UTC). ●Content is available under CC BY-SA 4.0 unless otherwise noted. ●Privacy policy ●About Wikipedia ●Disclaimers ●Contact Wikipedia ●Code of Conduct ●Developers ●Statistics ●Cookie statement ●Terms of Use ●Desktop